Mostrar el registro sencillo del ítem

Asociación entre mutaciones genómicas y susceptibilidad al desarrollo de lepra: Revisión sistemática y metaanálisis

dc.contributor.advisorChavarro Portillo, Bibiana
dc.contributor.advisorGuerrero Guerrero, Martha Inírida
dc.contributor.authorContreras Martínez, Laura Katherín
dc.date.accessioned2024-09-19T17:23:35Z
dc.date.available2024-09-19T17:23:35Z
dc.date.issued2024
dc.identifier.urihttps://repositorio.universidadmayor.edu.co/handle/unicolmayor/7054
dc.description.abstractLa lepra es una Enfermedad Tropical Desatendida y una neuropatía periférica no traumática, causada por M. leprae y M. lepromatosis. La respuesta inmune innata del huésped, controlada por varios genes, juega un papel importante en la determinación de la susceptibilidad a la lepra incluso antes de la infección inicial con el patógeno. Estas variantes se han observado en poblaciones de diferentes zonas endémicas a nivel mundial.spa
dc.description.tableofcontentsTabla de Contenido 1. INTRODUCCIÓN 12 2. MARCO TEORICO 14 2.1 Enfermedad de Hansen 14 2.2. Agente Causal de la lepra 15 2.3. Epidemiología de la lepra 16 2.4. Características clínicas de la lepra 17 2.5. Inmunología de la Lepra 18 2.5.1. Inmunidad innata 19 2.5.1.1. Acción de los Macrófagos 19 2.5.1.2. Células Dendríticas 20 2.5.2. Inmunidad Adaptativa 20 2.5.2.1. Linfocitos B 20 2.5.2.2. Linfocitos T 20 2.6. Marcadores genéticos en el hospedero 21 2.6.1. El Complejo mayor de histocompatibilidad (HLA) 21 2.6.2. Factor de necrosis tumoral (TNF) 22 2.6.3. Receptores tipo TOLL (TLR) 22 2.6.4. El dominio de oligomerización por unión de nucleótidos que contienen proteína dos (NOD2) 22 2.6.5. Interluquina 10 23 3. OBJETIVOS 24 3.1 Objetivo General 24 3.2 Objetivos específicos 24 4. MATERIALES Y MÉTODOS 25 4.1. Diseño del estudio 25 4.2. Búsqueda de las publicaciones 25 4.2.1. Términos clave 25 4.2.2. Criterios de inclusión y exclusión 26 4.3. Generación de base de datos 26 4.4. Análisis estadístico 26 4.5. Consideraciones éticas 27 5. RESULTADOS 28 5.1. Descripción de estudios incluidos 28 5.2. Datos demográficos de los estudios analizados. 32 5.2.1. Distribución geográfica de los estudios analizados 32 5.3. Análisis de mutaciones de susceptibilidad o resistencia a Lepra 33 5.3.1. Mutaciones en el gen de TNF 33 5.3.2. Mutaciones presentes en el gen IL-10. 34 5.3.3. Mutaciones presentes en el gen TLR1, TLR2, TLR4 y NOD2 en los casos y controles en los estudios analizados. 35 5.3.3.1. Mutaciones o polimorfismos en TLR1 35 5.3.3.2. Mutaciones o polimorfismos en TLR2 36 5.3.3.3. Mutaciones o polimorfismos en TLR4 37 5.3.3.4. Mutaciones o polimorfismos en NOD2 37 6. DISCUSIÓN 38 7. CONCLUSIONES 41 8. REFERENCIAS 42spa
dc.format.extent49p.spa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherUniversidad Colegio Mayor de Cundinamarcaspa
dc.rightsDerechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2024spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/spa
dc.titleAsociación entre mutaciones genómicas y susceptibilidad al desarrollo de lepra: Revisión sistemática y metaanálisisspa
dc.typeTrabajo de grado - Pregradospa
dc.contributor.corporatenameUniversidad Colegio Mayor de Cundinamarcaspa
dc.description.degreelevelPregradospa
dc.description.degreenameBacteriólogo(a) y Laboratorista Clínicospa
dc.publisher.facultyFacultad de Ciencias de la Saludspa
dc.publisher.placeBogotá D.Cspa
dc.publisher.programBacteriología y Laboratorio Clínicospa
dc.relation.referencesHan XY, Sizer KC, Velarde-Félix JS, Frias-Castro LO, Vargas-Ocampo F. The Leprosy Agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico. Int J Dermatol. 2012;51: 952–959. doi:10.1111/j.1365-4632.2011.05414.xspa
dc.relation.referencesBritton WJ, Lockwood DNJ. Leprosy. The Lancet. 2004;363: 1209–1219. doi:10.1016/S0140-6736(04)15952-7spa
dc.relation.referencesLepra - OPS/OMS | Organización Panamericana de la Salud. [cited 14 Oct 2022]. Available: https://www.paho.org/es/temas/lepraspa
dc.relation.referencesLockwood DNJ, Suneetha S. Leprosy: too complex a disease for a simple elimination paradigm. Bull World Health Organ. 2005/03/16 ed. 2005;83: 230–235.spa
dc.relation.referencesWHO - Global Leprosy Programme. Global Leprosy Strategy 2016-2020: Accelerating towards a leprosy-free world. 2016; 20.spa
dc.relation.referencesFine PE. Leprosy: the epidemiology of a slow bacterium. Epidemiol Rev. 1982;4: 161–88.spa
dc.relation.referencesInstituto Nacional de Salud. LEPRA, Periodo epidemiológico XIII. Colombia, 2019. 2019; Bogotá DC, Colombia. Available: https://www.ins.gov.co/buscador-eventos/Informesdeevento/LEPRA%20PE%20XIII%202019.pdfspa
dc.relation.referencesWHO. Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives. Weekly Epidemiological Record. 4 Sep 202095: 417–440.spa
dc.relation.referencesScollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The Continuing Challenges of Leprosy. Clin Microbiol Rev. 2006;19: 338. doi:10.1128/cmr.19.2.338-381.2006spa
dc.relation.referencesOliveira MBB de, Diniz LM. Leprosy among children under 15 years of age: literature review. An Bras Dermatol. 2016;91: 196–203. doi:10.1590/abd1806-4841.20163661spa
dc.relation.referencesMisch Elizabeth A., Berrington William R., Vary James C., Hawn Thomas R. Leprosy and the Human Genome. Microbiol Mol Biol Rev. 2010;74: 589–620. doi:10.1128/MMBR.00025-10spa
dc.relation.referencesWalker SL, Balagon M, Darlong J, Doni SN, Hagge DA, Halwai V, et al. ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum. PLoS Negl Trop Dis. 2015;9: e0004065. doi:10.1371/journal.pntd.0004065spa
dc.relation.referenceslesiones unguales en lepra.pdf.spa
dc.relation.referencesFakhouri R, Sotto MN, Manini MPI, Margarido LC. Nodular Leprosy of Childhood and Tuberculoid Leprosy: A Comparative, Morphologic, Immunopathologic and Quantitative Study of Skin Tissue Reaction. Int J Lepr Other Mycobact Dis. 2003;71: 218. doi:10.1489/1544-581X(2003)71<218:NLOCAT>2.0.CO;2spa
dc.relation.referencesMartha Inírida Guerrero, Gerzaín Rodríguez, Carlos Arturo Hernández. La lepra Una enfermedad vigente. Primera edición. Bogotá, D.C., Colombia: Panamericana Formas e Impresos, S. A.; 2019.spa
dc.relation.referencesLiu H, Bao F, Irwanto A, Fu X, Lu N, Yu G, et al. An association study of TOLL and CARD with leprosy susceptibility in Chinese population. Hum Mol Genet. 2013;22: 4430–4437. doi:10.1093/hmg/ddt286spa
dc.relation.referencesKrutzik SR, Ochoa MT, Sieling PA, Uematsu S, Ng YW, Legaspi A, et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med. 2003;9: 525–32. doi:10.1038/nm864spa
dc.relation.referencesBochud P-Y, Sinsimer D, Aderem A, Siddiqui MR, Saunderson P, Britton S, et al. Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy. Eur J Clin Microbiol Infect Dis. 2009;28: 1055–1065. doi:10.1007/s10096-009-0746-0spa
dc.relation.referencesCustodio LA, Saito A, Amarante MK, Fujita TC, Perim A de L, Costa IC, et al. Detection of Lsr2 gene of Mycobacterium leprae in nasal mucus. Braz Arch Biol Technol. 2012;55: 375–380. doi:10.1590/S1516-89132012000300007spa
dc.relation.referencesCardona Castro NM, Bedoya Berrío G. Lepra: enfermedad milenaria y actual. Iatreia. 2011;24: 51–64.spa
dc.relation.referencesPenna ML, Buhrer-Sekula S, Pontes MA, Cruz R, Goncalves Hde S, Penna GO. Primary results of clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): reactions frequency in multibacillary patients. Lepr Rev. 2012;83: 308–19.spa
dc.relation.referencesWHO. Global leprosy update, 2016: accelerating reduction of disease burden. Wkly Epidemiol Rec. 2017;35: 501–520.spa
dc.relation.referencesvan Brakel WH, Post E, Saunderson PR, Gopal PK. Leprosy. In: Quah SR, editor. International Encyclopedia of Public Health (Second Edition). Oxford: Academic Press; 2017. pp. 391–401. doi:10.1016/B978-0-12-803678-5.00251-4spa
dc.relation.referencesSugawara-Mikami M, Tanigawa K, Kawashima A, Kiriya M, Nakamura Y, Fujiwara Y, et al. Pathogenicity and virulence of Mycobacterium leprae. Virulence. 2022;13: 1985–2011. doi:10.1080/21505594.2022.2141987spa
dc.relation.referencesIsolation of Mycobacterium lepromatosis and Development of Molecular Diagnostic Assays to Distinguish Mycobacterium leprae and M. lepromatosis | Clinical Infectious Diseases | Oxford Academic. [cited 31 Oct 2022]. Available: https://academic.oup.com/cid/article/71/8/e262/5626481spa
dc.relation.referencesRamos-e-Silva M, Rebello PF. Leprosy. Recognition and treatment. Am J Clin Dermatol. 2001;2: 203–11.spa
dc.relation.referencesRodrigues LC, Lockwood DNJ. Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect Dis. 2011;11: 464–470. doi:10.1016/s1473-3099(11)70006-8spa
dc.relation.referencesNoordeen SK. Elimination of leprosy as a public health problem. Indian J Lepr. 1994;66: 1–10.spa
dc.relation.referencesDeps P, Collin SM. Mycobacterium lepromatosis as a Second Agent of Hansen’s Disease. Front Microbiol. 2021;12: 698588. doi:10.3389/fmicb.2021.698588spa
dc.relation.referencesArocha F, Valero N, Hassanhi M, DeWard J, Rodríguez Z, Maldonado M, et al. Anticuerpos séricos antiglicolípido fenólico 1 en personal de centros de salud en contacto con pacientes con enfermedad de Hansen. Kasmera. 2006;34: 102–113.spa
dc.relation.referencesChavarro-Portillo B, Colorado CL, Guerrero MI. Mycobacterium leprae. En: Guerrero MI, Hernández CA y Rodríguez G Editores La lepra: una enfermedad vigente Centro Dermatológico Federico Lleras Acosta Bogotá DC, Colombia Panamericana Formas e Impresos. 2019. pp. 63–87.spa
dc.relation.references2024_Boletín_epidemiologico_semana_2.pdf.spa
dc.relation.referencesMisch EA, Berrington WR, Vary JC, Hawn TR. Leprosy and the Human Genome. Microbiol Mol Biol Rev MMBR. 2010;74: 589–620. doi:10.1128/mmbr.00025-10spa
dc.relation.referencesNunzi E, Massone C, Noto S. Clinical Features. In: Nunzi E, Massone C, editors. Leprosy. Springer Milan; 2012. pp. 75–110. doi:10.1007/978-88-470-2376-5_10spa
dc.relation.referencesMontoya D, Cruz D, Teles RMB, Lee DJ, Ochoa MT, Krutzik SR, et al. Divergence of Macrophage Phagocytic and Antimicrobial Programs in Leprosy. Cell Host Microbe. 2009;6: 343–353. doi:10.1016/j.chom.2009.09.002spa
dc.relation.referencesSaini C, Ramesh V, Nath I. CD4+ Th17 Cells Discriminate Clinical Types and Constitute a Third Subset of Non Th1, Non Th2 T Cells in Human Leprosy. PLoS Negl Trop Dis. 2013;7: e2338. doi:10.1371/journal.pntd.0002338spa
dc.relation.referencesAlter A, Grant A, Abel L, Alcaïs A, Schurr E. Leprosy as a genetic disease. Mamm Genome. 2011;22: 19–31. doi:10.1007/s00335-010-9287-1spa
dc.relation.referencesKoçak M, Balcı M, Pençe B, Kundakçı N. Associations between human leukocyte antigens and leprosy in the Turkish population. Clin Exp Dermatol. 2002;27: 235–239. doi:10.1046/j.1365-2230.2002.01004.xspa
dc.relation.referencesAreeshi MY, Mandal RK, Dar SA, Jawed A, Wahid M, Lohani M, et al. Impact of TNF -308 G&gt;A (rs1800629) gene polymorphism in modulation of leprosy risk: a reappraise meta-analysis of 14 case–control studies. Biosci Rep. 2017;37: BSR20170806. doi:10.1042/BSR20170806spa
dc.relation.referencesMisch EA, Macdonald M, Ranjit C, Sapkota BR, Wells RD, Siddiqui MR, et al. Human TLR1 Deficiency Is Associated with Impaired Mycobacterial Signaling and Protection from Leprosy Reversal Reaction. Correa-Oliveira R, editor. PLoS Negl Trop Dis. 2008;2: e231. doi:10.1371/journal.pntd.0000231spa
dc.relation.referencesLeturiondo AL, Noronha AB, Mendonça CYR, Ferreira C de O, Alvarado-Arnez LE, Manta FS de N, et al. Association of NOD2 and IFNG single nucleotide polymorphisms with leprosy in the Amazon ethnic admixed population. Bochud P-Y, editor. PLoS Negl Trop Dis. 2020;14: e0008247. doi:10.1371/journal.pntd.0008247spa
dc.relation.referencesFiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol Baltim Md 1950. 1991;146: 3444–3451.spa
dc.relation.referencesGutierrez-Castañeda LD, Acosta CR, Bustos MA, García DK, Bohada DP, Rodríguez R, et al. Single Nucleotide Variants in the TLR1, TLR2 and TLR6 Genes: A Case–Control Study in a Colombian Population. Trop Med Infect Dis. 2023;8: 473. doi:10.3390/tropicalmed8100473spa
dc.relation.referencesBustos MA, Castañeda-Castañeda LD, Acosta CR, García D, Bohada DP, Rodríguez R, et al. Association of the rs2111234, rs3135499, rs8057341 polymorphisms in the NOD2 gene with leprosy: A case-control study in the Norte de Santander, Colombia population. Boon-Peng H, editor. PLOS ONE. 2023;18: e0281553. doi:10.1371/journal.pone.0281553spa
dc.relation.referencesMasin PS, Visentin HA, Elpidio LNS, Sell AM, Visentainer L, Lima Neto QAD, et al. Genetic polymorphisms of toll-like receptors in leprosy patients from southern Brazil. Front Genet. 2022;13: 952219. doi:10.3389/fgene.2022.952219spa
dc.relation.referencesda Silva MNS, da Veiga Borges Leal DF, Sena C, Pinto P, Gobbo AR, da Silva MB, et al. Association between SNPs in microRNAs and microRNAs-Machinery Genes with Susceptibility of Leprosy in the Amazon Population. Int J Mol Sci. 2022;23: 10628. doi:10.3390/ijms231810628spa
dc.relation.referencesDa Silva MNS, Da Veiga Borges Leal DF, Sena C, Pinto P, Gobbo AR, Da Silva MB, et al. Association between SNPs in microRNAs and microRNAs-Machinery Genes with Susceptibility of Leprosy in the Amazon Population. Int J Mol Sci. 2022;23: 10628. doi:10.3390/ijms231810628spa
dc.relation.referencesdos Santos EC, Silvestre M do PSCA, Paz JLP, Machado RLD, Lima LNGC. Study of TNF-α, IFN-γ, TGF-β, IL-6, and IL-10 Gene Polymorphism in Individuals from the Leprosy-Endemic Area in the Brazilian Amazon. J Interferon Cytokine Res. 2021;41: 125–131. doi:10.1089/jir.2018.0162spa
dc.relation.referencesTiyo BT, Vendramini ECL, de Souza VH, Colli CM, Alves HV, Sell AM, et al. Association of MBL2 Exon 1 Polymorphisms With Multibacillary Leprosy. Front Immunol. 2020;11: 1927. doi:10.3389/fimmu.2020.01927spa
dc.relation.referencesPragasam V, Vasudevan B, Moorchung N. Cytokine gene polymorphisms in type I and type II reactions in Hansen’s disease. Indian J Dermatol Venereol Leprol. 2020;86: 482. doi:10.4103/ijdvl.IJDVL_619_18spa
dc.relation.referencesTarique M, Naz H, Saini C, Suhail M, Shankar H, Khanna N, et al. Association of IL-10 Gene Polymorphism With IL-10 Secretion by CD4 and T Regulatory Cells in Human Leprosy. Front Immunol. 2020;11: 1974. doi:10.3389/fimmu.2020.01974spa
dc.relation.referencesAlvarenga Niitsuma EN, Fernandes G da R, Lana FCF. The TLR1 gene is associated with higher protection from leprosy in women. Arez AP, editor. PLOS ONE. 2018;13: e0205234. doi:10.1371/journal.pone.0205234spa
dc.relation.referencesAlmasi S, Aliparasti MR, Naghili B, Yeganeh K, Rahnama B, Tavanafar F, et al. Analysis of CTLA-4 + 49A/G gene polymorphism in cases with leprosy of Azerbaijan, Northwest Iran. Infect Genet Evol. 2018;57: 121–127. doi:10.1016/j.meegid.2017.11.001spa
dc.relation.referencesSales-Marques C, Cardoso CC, Alvarado-Arnez LE, Illaramendi X, Sales AM, Hacker M de A, et al. Genetic polymorphisms of the IL6 and NOD2 genes are risk factors for inflammatory reactions in leprosy. Azman AS, editor. PLoS Negl Trop Dis. 2017;11: e0005754. doi:10.1371/journal.pntd.0005754spa
dc.relation.referencesWang D, Zhang D-F, Li G-D, Bi R, Fan Y, Wu Y, et al. A pleiotropic effect of the APOE gene: association of APOE polymorphisms with multibacillary leprosy in Han Chinese from Southwest China. Br J Dermatol. 2018;178: 931–939. doi:10.1111/bjd.16020spa
dc.relation.referencesSantana NDL, Rêgo JL, Oliveira JM, Almeida LFD, Braz M, Machado LMM, et al. Polymorphisms in genes TLR1, 2 and 4 are associated with differential cytokine and chemokine serum production in patients with leprosy. Mem Inst Oswaldo Cruz. 2017;112: 260–268. doi:10.1590/0074-02760160366spa
dc.relation.referencesDubey A, Biswas SK, Sinha E, Chakma JK, Kamal R, Arora M, et al. Association of Nitric Oxide Synthase2 gene polymorphisms with leprosy reactions in northern Indian population. Infect Genet Evol. 2017;51: 67–73. doi:10.1016/j.meegid.2017.03.015spa
dc.relation.referencesYuan Y, You Y, Wen Y, Liu J, Li H, Zhang Y, et al. Identification of novel genetic loci GAL3ST4 and CHGB involved in susceptibility to leprosy. Sci Rep. 2017;7: 16352. doi:10.1038/s41598-017-16422-1spa
dc.relation.referencesOliveira JM, Rêgo JL, De Lima Santana N, Braz M, Jamieson SE, Vieira TS, et al. The − 308 bp TNF gene polymorphism influences tumor necrosis factor expression in leprosy patients in Bahia State, Brazil. Infect Genet Evol. 2016;39: 147–154. doi:10.1016/j.meegid.2016.01.026spa
dc.relation.referencesMedeiros P, Da Silva WL, De Oliveira Gimenez BB, Vallezi KB, Moraes MO, De Souza VNB, et al. The GATA3 gene is involved in leprosy susceptibility in Brazilian patients. Infect Genet Evol. 2016;39: 194–200. doi:10.1016/j.meegid.2016.01.015spa
dc.relation.referencesRamos GB, Salomão H, Francio AS, Fava VM, Werneck RI, Mira MT. Association Analysis Suggests SOD2 as a Newly Identified Candidate Gene Associated With Leprosy Susceptibility. J Infect Dis. 2016;214: 475–478. doi:10.1093/infdis/jiw170spa
dc.relation.referencesBrochado MJF, Gatti MFC, Zago MA, Roselino AM. Association of the solute carrier family 11 member 1 gene polymorphisms with susceptibility to leprosy in a Brazilian sample. Mem Inst Oswaldo Cruz. 2016;111: 101–105. doi:10.1590/0074-02760150326spa
dc.relation.referencesMartinez-Guzman MA, Alvarado-Navarro A, Pereira-Suarez AL, Muñoz-Valle JF, Fafutis-Morris M. Association between STR -794 CATT 5-8 and SNP -173 G/C polymorphisms in the MIF gene and Lepromatous Leprosy in Mestizo patients of western Mexico. Hum Immunol. 2016;77: 985–989. doi:10.1016/j.humimm.2016.07.006spa
dc.relation.referencesLi G-D, Wang D, Zhang D-F, Xiang Q, Feng J-Q, Li X-A, et al. Fine mapping of the GWAS loci identifies SLC35D1 and IL23R as potential risk genes for leprosy. J Dermatol Sci. 2016;84: 322–329. doi:10.1016/j.jdermsci.2016.09.018spa
dc.relation.referencesTarique M, Naqvi RA, Santosh KV, Kamal VK, Khanna N, Rao DN. Association of TNF-α-308(GG), IL-10−819(TT), IL-10−1082(GG) and IL-1R1+1970(CC) genotypes with the susceptibility and progression of leprosy in North Indian population. Cytokine. 2015;73: 61–65. doi:10.1016/j.cyto.2015.01.014spa
dc.relation.referencesSilva GAV, Ramasawmy R, Boechat AL, Morais AC, Carvalho BKS, Sousa KBA, et al. Association of TNF −1031 C/C as a potential protection marker for leprosy development in Amazonas state patients, Brazil. Hum Immunol. 2015;76: 137–141. doi:10.1016/j.humimm.2015.01.011spa
dc.relation.referencesSykam A, Gutlapalli VR, Tenali SP, Meena AK, Chandran P, Pratap DVS, et al. Association of tumor necrosis factor-alpha and interferon gamma gene polymorphisms and their plasma levels in leprosy, HIV and other peripheral neuropathies. Cytokine. 2015;76: 473–479. doi:10.1016/j.cyto.2015.09.010spa
dc.relation.referencesSales-Marques C, Salomão H, Fava VM, Alvarado-Arnez LE, Amaral EP, Cardoso CC, et al. NOD2 and CCDC122-LACC1 genes are associated with leprosy susceptibility in Brazilians. Hum Genet. 2014;133: 1525–1532. doi:10.1007/s00439-014-1502-9spa
dc.relation.referencesCezar-de-Mello PFT, Toledo-Pinto TG, Marques CS, Arnez LEA, Cardoso CC, Guerreiro LTA, et al. Pre-miR-146a (rs2910164 G>C) Single Nucleotide Polymorphism Is Genetically and Functionally Associated with Leprosy. Small PLC, editor. PLoS Negl Trop Dis. 2014;8: e3099. doi:10.1371/journal.pntd.0003099spa
dc.relation.referencesEscamilla-Tilch M, Estrada-García I, Granados J, Arenas-Guzmán R, Ramos-Payan R, Pérez-Suárez TG, et al. Lack of Association of the Polymorphisms IL-17A (−197G/A) and IL-17F (+7488A/G) with Multibacillary Leprosy in Mexican Patients. Int J Genomics. 2014;2014: 1–5. doi:10.1155/2014/920491spa
dc.relation.referencesChaitanya VS, Jadhav RS, Lavania M, Singh M, Valluri V, Sengupta U. Interleukin‐17F single‐nucleotide polymorphism (7488T>C) and its association with susceptibility to leprosy. Int J Immunogenet. 2014;41: 131–137. doi:10.1111/iji.12097spa
dc.relation.referencesSilva GAV, Santos MP, Motta-Passos I, Boechat AL, Malheiro A, Ramasawmy R, et al. Polymorphisms assessment in the promoter region of IL12RB2 in Amazon leprosy patients. Hum Immunol. 2014;75: 592–596. doi:10.1016/j.humimm.2014.01.009spa
dc.relation.referencesWang D, Xu L, Lv L, Su L-Y, Fan Y, Zhang D-F, et al. Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China. Genes Immun. 2015;16: 112–119. doi:10.1038/gene.2014.72spa
dc.relation.referencesMarcinek P, Jha AN, Shinde V, Sundaramoorthy A, Rajkumar R, Suryadevara NC, et al. LRRK2 and RIPK2 Variants in the NOD 2-Mediated Signaling Pathway Are Associated with Susceptibility to Mycobacterium leprae in Indian Populations. Fritz JH, editor. PLoS ONE. 2013;8: e73103. doi:10.1371/journal.pone.0073103spa
dc.relation.referencesMontoya-Buelna M, Fafutis-Morris M, Tovar-Cuevas AJ, Alvarado-Navarro A, Valle Y, Padilla-Gutierrez JR, et al. Role of Toll-Interacting Protein Gene Polymorphisms in Leprosy Mexican Patients. BioMed Res Int. 2013;2013: 1–7. doi:10.1155/2013/459169spa
dc.relation.referencesShinde V, Marcinek P, Rani DS, Sunder SR, Arun S, Jain S, et al. Genetic evidence of TAP1 gene variant as a susceptibility factor in Indian leprosy patients. Hum Immunol. 2013;74: 803–807. doi:10.1016/j.humimm.2013.01.001spa
dc.relation.referencesZhang D-F, Huang X-Q, Wang D, Li Y-Y, Yao Y-G. Genetic variants of complement genes Ficolin-2, Mannose-binding lectin and Complement factor H are associated with leprosy in Han Chinese from Southwest China. Hum Genet. 2013;132: 629–640. doi:10.1007/s00439-013-1273-8spa
dc.relation.referencesYang D, Chen J, Shi C, Jing Z, Song N. Autophagy Gene Polymorphism is Associated with Susceptibility to Leprosy by Affecting Inflammatory Cytokines. Inflammation. 2014;37: 593–598. doi:10.1007/s10753-013-9773-1spa
dc.relation.referencesSuryadevara NC, Neela VSK, Kovvali S, Pydi SS, Jain S, Siva Sai K, et al. Genetic association of G896A polymorphism of TLR4 gene in leprosy through family-based and case-control study designs. Trans R Soc Trop Med Hyg. 2013;107: 777–782. doi:10.1093/trstmh/trt084spa
dc.relation.referencesAlvarado-Arnez LE, Amaral EP, Sales-Marques C, M. B. Durães S, C. Cardoso C, Nunes Sarno E, et al. Association of IL10 Polymorphisms and Leprosy: A Meta-Analysis. Islam FMA, editor. PLOS ONE. 2015;10: e0136282. doi:10.1371/journal.pone.0136282spa
dc.relation.referencesChen XH, Xiong JH, Ning Y, Wen Y, Liu J, Mao C, et al. IL-10 promoter SNPs and susceptibility to leprosy in ethnic groups from southwest China. Genet Mol Res. 2013;12: 2876–2885. doi:10.4238/2013.August.12.3spa
dc.relation.referencesCardona-Castro N, Sánchez-Jiménez M, Rojas W, Bedoya-Berrío G. IL-10 gene promoter polymorphisms and leprosy in a Colombian population sample. Biomédica. 2012;32: 71–76.spa
dc.relation.referencesWang D, Feng J-Q, Li Y-Y, Zhang D-F, Li X-A, Li Q-W, et al. Genetic variants of the MRC1 gene and the IFNG gene are associated with leprosy in Han Chinese from Southwest China. Hum Genet. 2012;131: 1251–1260. doi:10.1007/s00439-012-1153-7spa
dc.relation.referencesAli S, Srivastava AK, Chopra R, Aggarwal S, Garg VK, Bhattacharya SN, et al. IL12B SNPs and copy number variation in IL23R gene associated with susceptibility to leprosy. J Med Genet. 2013;50: 34–42. doi:10.1136/jmedgenet-2012-101214spa
dc.relation.referencesSilva GAV, Santos MP, Mota-Passos I, Boechat AL, Malheiro A, Naveca FG, et al. IFN-γ +875 microsatellite polymorphism as a potential protection marker for leprosy patients from Amazonas state, Brazil. Cytokine. 2012;60: 493–497. doi:10.1016/j.cyto.2012.04.043spa
dc.relation.referencesAli S, Chopra R, Aggarwal S, Srivastava AK, Kalaiarasan P, Malhotra D, et al. Association of variants in BAT1-LTA-TNF-BTNL2 genes within 6p21.3 region show graded risk to leprosy in unrelated cohorts of Indian population. Hum Genet. 2012;131: 703–716. doi:10.1007/s00439-011-1114-6spa
dc.relation.referencesAggarwal S, Ali S, Chopra R, Srivastava A, Kalaiarasan P, Malhotra D, et al. Genetic Variations and Interactions in Anti-inflammatory Cytokine Pathway Genes in the Outcome of Leprosy: A Study Conducted on a MassARRAY Platform. J Infect Dis. 2011;204: 1264–1273. doi:10.1093/infdis/jir516spa
dc.relation.referencesCardoso CC, Pereira AC, Brito-de-Souza VN, Duraes SMB, Ribeiro-Alves M, Augusto C. Nery J, et al. TNF -308G>A Single Nucleotide Polymorphism Is Associated With Leprosy Among Brazilians: A Genetic Epidemiology Assessment, Meta-Analysis, and Functional Study. J Infect Dis. 2011;204: 1256–1263. doi:10.1093/infdis/jir521spa
dc.relation.referencesCardoso CC, Pereira AC, Brito-de-Souza VN, Dias-Baptista IM, Maniero VC, Venturini J, et al. IFNG +874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians. Hum Genet. 2010;128: 481–490. doi:10.1007/s00439-010-0872-xspa
dc.relation.referencesPereira A, Brito-de-Souza V, Cardoso C, Dias-Baptista I, Parelli F, Venturini J, et al. Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for À819C/T in leprosy susceptibility. Genes Immun.spa
dc.relation.referencesFranceschi DSA, Mazini PS, Rudnick CCC, Sell AM, Tsuneto LT, Ribas ML, et al. Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. Int J Infect Dis. 2009;13: 493–498. doi:10.1016/j.ijid.2008.08.019spa
dc.relation.referencesSettin A, Nassar S, Abdel-Latif A, Elbaz R, El-Mongy S, Hassan A, et al. Association of Cytokine Gene Polymorphism with Susceptibility and Clinical Types of Leprosy. Int J Health Sci. 2007;1: 25–33.spa
dc.relation.referencesMalhotra D, Darvishi K, Lohra M, Kumar H, Grover C, Sood S, et al. Association study of major risk single nucleotide polymorphisms in the common regulatory region of PARK2 and PACRG genes with leprosy in an Indian population. Eur J Hum Genet. 2006;14: 438–442. doi:10.1038/sj.ejhg.5201563spa
dc.relation.referencesMalhotra D, Darvishi K, Sood S, Sharma S, Grover C, Relhan V, et al. IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy. Hum Genet. 2005;118: 295–300. doi:10.1007/s00439-005-0042-8spa
dc.relation.referencesObject object. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi. [cited 3 Apr 2024]. Available: https://core.ac.uk/reader/13107345?utm_source=linkoutspa
dc.relation.referencesLee S-B, Kim BC, Jin SH, Park Y-G, Kim S-K, Kang T-J, et al. Missense mutations of the interleukin-12 receptor beta 1(IL12RB1) and interferon-gamma receptor 1 (IFNGR1) genes are not associated with susceptibility to lepromatous leprosy in Korea. Immunogenetics. 2003;55: 177–181. doi:10.1007/s00251-003-0573-xspa
dc.relation.referencesWibawa T, Soebono H, Matsuo M. Association of a missense mutation of the laminin α2 gene with tuberculoid type of leprosy in Indonesian patients. Trop Med Int Health. 2002;7: 631–636. doi:10.1046/j.1365-3156.2002.00908.xspa
dc.relation.referencesSantos AR, Suffys PN, Vanderborght PR, Moraes MO, Vieira LMM, Cabello PH, et al. Role of Tumor Necrosis Factor–a and Interleukin-10 Promoter Gene Polymorphisms in Leprosy.spa
dc.relation.referencesPrimeros Mapas Del Mundo Mapa Del Mundo Diverso Poster Mundo Png Images. [cited 1 Apr 2024]. Available: https://www.tpsearchtool.com/images/primeros-mapas-del-mundo-mapa-del-mundo-diverso-poster-mundo-png#images-17spa
dc.relation.referencesWHO. Multidrug therapy (MDT). In: WHO [Internet]. 9 Feb 2020 [cited 9 Feb 2020]. Available: http://www.who.int/lep/mdt/en/spa
dc.relation.referencesWHO. Global leprosy (Hansen disease) update, 2021: moving towards interruption of transmission. Wkly Epidemiol Rec WER. 2022;97: 429–452.spa
dc.relation.referencesOliveira MBB de, Diniz LM. Leprosy among children under 15 years of age: literature review. An Bras Dermatol. 2016;91: 196–203. doi:10.1590/abd1806-4841.20163661spa
dc.relation.referencesWHO Technical Advisory Group on Elimination of Leprosy. Meeting (3rd: 2002: Brasilia B, World Health Organization. Strategy Development and Monitoring for Eradication and Elimination Team, Leprosy Elimination Advisory Group. Meeting. Report on third meeting of the WHO Technical Advisory Group on Elimination of Leprosy, Brasilia, 1 and 2 February 2002. Rapp Trois La Réun Groupe Consult Tech OMS Sur Lélimination Lèpre Bras 1 2 Février 2002. 2002. Available: https://apps.who.int/iris/handle/10665/67302spa
dc.relation.referencesWHO. Global leprosy (Hansen disease) update, 2022: new paradigm – control to elimination. Wkly Epidemiol Rec. 2023;98: 409–430.spa
dc.relation.referencesVarkevisser CM, Lever P, Alubo O, Burathoki K, Idawani C, Moreira TMA, et al. Gender and leprosy: case studies in Indonesia, Nigeria, Nepal and Brazil. Lepr Rev. 2009;80: 65–76.spa
dc.relation.referencesLiu Y-Y, Yu M-W, Ning Y, Wang H. A study on gender differences in newly detected leprosy cases in Sichuan, China, 2000–2015. Int J Dermatol. 2018;57: 1492–1499. doi:10.1111/ijd.14148spa
dc.relation.referencesMisch EA, Macdonald M, Ranjit C, Sapkota BR, Wells RD, Siddiqui MR, et al. Human TLR1 Deficiency Is Associated with Impaired Mycobacterial Signaling and Protection from Leprosy Reversal Reaction. PLoS Negl Trop Dis. 2008;2: e231. doi:10.1371/journal.pntd.0000231spa
dc.relation.referencesKleinnijenhuis J, Oosting M, Joosten LAB, Netea MG, Van Crevel R. Innate Immune Recognition of Mycobacterium tuberculosis. Kawai T, editor. Clin Dev Immunol. 2011;2011: 405310. doi:10.1155/2011/405310spa
dc.relation.referencesMichelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci. 2004;101: 10679–10684. doi:10.1073/pnas.0403249101spa
dc.relation.referencesBerrington WR, Macdonald M, Khadge S, Sapkota BR, Janer M, Hagge DA, et al. Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states. J Infect Dis. 2010;201: 1422–1435. doi:10.1086/651559spa
dc.relation.referencesHampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn’s disease: a cohort study. The Lancet. 2002;359: 1661–1665. doi:10.1016/S0140-6736(02)08590-2spa
dc.relation.referencesNOD2 and CCDC122‑LACC1 genes are associated with leprosy.pdf.spa
dc.relation.referencesEstudio de asociación de genoma completo (GWAS). [cited 17 Feb 2024]. Available: https://www.genome.gov/es/genetics-glossary/Estudio-de-asociacion-de-genoma-completospa
dc.rights.accessrightsinfo:eu-repo/semantics/closedAccessspa
dc.rights.creativecommonsAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)spa
dc.subject.proposalLepraspa
dc.subject.proposalMarcadores genéticosspa
dc.subject.proposalSusceptibilidadspa
dc.type.coarhttp://purl.org/coar/resource_type/c_7a1fspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/bachelorThesisspa
dc.type.redcolhttps://purl.org/redcol/resource_type/TPspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.rights.coarhttp://purl.org/coar/access_right/c_14cbspa


Ficheros en el ítem

Thumbnail
Nombre:
Asociación entre mutaciones ...
Tamaño:
2.613Mb
Formato:
PDF
Ver/
Thumbnail
Nombre:
CARTA DERECHOS DE AUTOR IP ...
Tamaño:
98.61Kb
Formato:
PDF
Ver/
Thumbnail
Nombre:
FORMATO IDENTIFICACIÓN TRABAJOS ...
Tamaño:
164.8Kb
Formato:
PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2024
Excepto si se señala otra cosa, la licencia del ítem se describe como Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2024